Enanta Pharmaceuticals Inc (ENTA) — Capital Reinvestment Ratio
Enanta Pharmaceuticals Inc (ENTA) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow ($17.51 Million) in capital expenditures ($155.00K). See debt-free asset ratio of Enanta Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Enanta Pharmaceuticals Inc Capital Reinvestment Ratio (2011–2020)
This chart tracks Enanta Pharmaceuticals Inc's Capital Reinvestment Ratio across 10 annual periods. Check ENTA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year Capital Reinvestment Ratio for Enanta Pharmaceuticals Inc from 2011 to 2020. For live market cap and broader valuation context, see ENTA market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.20x | $7.09 Million | $1.45 Million | ▲ +168.8% |
| 2019 | 0.08x | $71.42 Million | $5.42 Million | ▼ -25.7% |
| 2018 | 0.10x | $29.22 Million | $2.98 Million | ▲ +114.4% |
| 2017 | 0.05x | $52.65 Million | $2.51 Million | ▼ -64.0% |
| 2016 | 0.13x | $35.81 Million | $4.74 Million | ▲ +334.3% |
| 2015 | 0.03x | $76.67 Million | $2.34 Million | ▼ -40.2% |
| 2014 | 0.05x | $20.18 Million | $1.03 Million | ▼ -10.4% |
| 2013 | 0.06x | $10.65 Million | $606.00K | ▲ +410.7% |
| 2012 | 0.01x | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $24.02 Million | $445.00K | — |